1. Home
  2. ESE vs MDGL Comparison

ESE vs MDGL Comparison

Compare ESE & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESE
  • MDGL
  • Stock Information
  • Founded
  • ESE 1990
  • MDGL 2011
  • Country
  • ESE United States
  • MDGL United States
  • Employees
  • ESE N/A
  • MDGL N/A
  • Industry
  • ESE Telecommunications Equipment
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESE Telecommunications
  • MDGL Health Care
  • Exchange
  • ESE Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • ESE 5.4B
  • MDGL 6.1B
  • IPO Year
  • ESE N/A
  • MDGL N/A
  • Fundamental
  • Price
  • ESE $210.48
  • MDGL $427.05
  • Analyst Decision
  • ESE Strong Buy
  • MDGL Strong Buy
  • Analyst Count
  • ESE 2
  • MDGL 10
  • Target Price
  • ESE $187.50
  • MDGL $474.67
  • AVG Volume (30 Days)
  • ESE 235.2K
  • MDGL 349.9K
  • Earning Date
  • ESE 11-13-2025
  • MDGL 10-30-2025
  • Dividend Yield
  • ESE 0.15%
  • MDGL N/A
  • EPS Growth
  • ESE 14.55
  • MDGL N/A
  • EPS
  • ESE 4.43
  • MDGL N/A
  • Revenue
  • ESE $1,123,852,000.00
  • MDGL $515,547,000.00
  • Revenue This Year
  • ESE $17.55
  • MDGL $394.12
  • Revenue Next Year
  • ESE $12.43
  • MDGL $57.74
  • P/E Ratio
  • ESE $47.19
  • MDGL N/A
  • Revenue Growth
  • ESE 22.39
  • MDGL 3421.98
  • 52 Week Low
  • ESE $118.96
  • MDGL $200.63
  • 52 Week High
  • ESE $211.25
  • MDGL $457.16
  • Technical
  • Relative Strength Index (RSI)
  • ESE 65.50
  • MDGL 59.53
  • Support Level
  • ESE $200.19
  • MDGL $418.36
  • Resistance Level
  • ESE $210.79
  • MDGL $440.90
  • Average True Range (ATR)
  • ESE 4.68
  • MDGL 13.53
  • MACD
  • ESE 0.81
  • MDGL -4.66
  • Stochastic Oscillator
  • ESE 95.52
  • MDGL 22.40

About ESE ESCO Technologies Inc.

ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: